Evidence map›Paper›PMID 26428678›Full record

ArticleJournal of leukocyte biology2016

γδ T cells protect against LPS-induced lung injury.

Fabian Wehrmann, James C Lavelle, Colm B Collins, Alex N Tinega, Joshua M Thurman, Ellen L Burnham, Philip L Simonian

Open access · bronzeAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Gut-derived immune cells and the gut-lung axis in ARDS.Critical care (London, England) · 2024
    Review
  2. Article
  3. Article
  4. Frontiers in immunology · 2021
    Article
  5. Article
  6. Reparative T lymphocytes in organ injury.The Journal of clinical investigation · 2019
    Review
  7. Article
  8. In vivo lung perfusion rehabilitates sepsis-induced lung injury.The Journal of thoracic and cardiovascular surgery · 2018
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Fabian WehrmannDepartments of *Medicine and Pediatrics, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
James C LavelleDepartments of *Medicine and Pediatrics, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
Colm B CollinsDepartments of *Medicine and Pediatrics, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
Alex N TinegaDepartments of *Medicine and Pediatrics, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
Joshua M ThurmanDepartments of *Medicine and Pediatrics, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
Ellen L BurnhamDepartments of *Medicine and Pediatrics, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
Philip L SimonianDepartments of *Medicine and Pediatrics, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA philip.simonian@ucdenver.edu.
University of Colorado Anschutz Medical Campus · US

Funding

Supplement: CoPARC: Colorado Pulmonary Alcohol Research CollaborativeR24AA019661 · NIAAA · UNIVERSITY OF COLORADO DENVER · PI ELLEN L BURNHAM · 2011 to 2026
$8.5M
IL-22 Protection in a Murine Model of Hypersensitivity PneumonitisR01HL113027 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI SIMONIAN, PHILIP LEVON · 2012 to 2016
$1.8M
NHLBI NIH HHS HL113027NHLBI NIH HHS R01 HL113027NIAAA NIH HHS R24 AA019661
6 · The paper itself

Abstract

γδ T lymphocytes are a unique T cell population with important anti-inflammatory capabilities. Their role in acute lung injury, however, is poorly understood but may provide significant insight into lung-protective mechanisms occurring after injury. In a murine model of lung injury, wild-type C57BL/6 and TCRδ(-/-) mice were exposed to Escherichia coli LPS, followed by analysis of γδ T cell and macrophage subsets. In the absence of γδ T cells, TCRδ(-/-) mice developed increased inflammation and alveolar-capillary leak compared with wild-type C57BL/6 mice after LPS exposure that correlated with expansion of distinct macrophage populations. Classically activated M1 macrophages were increased in the lung of TCRδ(-/-) mice at d 1, 4, and 7 after LPS exposure that peaked at d 4 and persisted at d 7 compared with wild-type animals. In response to LPS, Vγ1 and Vγ7 γδ T cells were expanded in the lung and expressed IL-4. Coculture experiments showed decreased expression of TNF-α by resident alveolar macrophages in the presence of γδ T cells that was reversed in the presence of an anti-IL-4-blocking antibody. Treatment of mice with rIL4 resulted in reduced numbers of M1 macrophages, inflammation, and alveolar-capillary leak. Therefore, one mechanism by which Vγ1 and Vγ7 γδ T cells protect against LPS-induced lung injury is through IL-4 expression, which decreases TNF-α production by resident alveolar macrophages, thus reducing accumulation of M1 macrophages, inflammation, and alveolar-capillary leak.

Indexed as

Acute Lung InjuryAnimalsBronchoalveolar Lavage FluidCapillary Leak SyndromeCoculture TechniquesGene Rearrangement, delta-Chain T-Cell Antigen ReceptorGene Rearrangement, gamma-Chain T-Cell Antigen ReceptorInflammationInterleukin-4LipopolysaccharidesMacrophages, AlveolarMiceMice, Inbred C57BLReceptors, Antigen, T-Cell, gamma-deltaRecombinant ProteinsT-Lymphocyte SubsetsInterleukin-4lipopolysaccharide, E coli O55-B5LipopolysaccharidesReceptors, Antigen, T-Cell, gamma-deltaRecombinant ProteinsTumor Necrosis Factor-alphaalveolar-capillary leakARDSIL-4macrophagesTNF-α

Identifiers

PMID26428678
PMCPMC4718194
OpenAlexW2224254481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.